This person is not registered. Is this you?


Profile Details
Jinghai Xu
Affiliations:

Pfizer

Merck

 
, USA
Phone:
Fax:
My Blogs:
My Twitter Hashtags:
@JShoee
 
Age:
Bio:
 
Specialty:
Cancer Biology, Cancer Immunotherapy
 
Presented at Events Covering:
, Biology, Cancer Biology, Cell Biology, Drug Design
 
Areas of Interest:
 
Hobbies:
 
General Comments:
BSN Rank: 1099 / 2941 (What's this?)
Accomplish Score: 77
Popularity Score: Unavailable
# in My Circle: 0
# in My Org(s): 555
We'll Post Your CV for Free!
 
 
Speaking/Presenting-Abstract/Poster at Mtg: 4 (53 / 0)
 
Honors and Awards: 0 (0 / 0)
 
Clinical Trial Activity: 0 (0 / 0)
 
Grant Support: 0 (0 / 0)
 
Patents Pending: 0 (0 / 0)
 
Journal - Editor/Reviewer: 0 (0 / 0)
 
Peer Reviewed Papers, Books, Chapters: 4 (24 / 0)
  • Prostate cancer (PCa) is a common cancer and remains the second-leading cause of cancer-associated mortality in men, but diagnosis of PCa remains a main clinical challenge. ()
  • Although adoptive immunotherapy (AIT) is a novel emerging target treatment for non-small cell lung cancer (NSCLC), its actual efficacy remains controversial. ()
  • We describe the clinical, morphologic, immunophenotypic and molecular genetic features of 15 cases of acute myeloid leukemia (AML) with t(4;12)(q12;p13). ()
 
Pre/Non Reviewed Papers, Proceedings: 0 (0 / 0)
 
Membership in Professional Societies: 0 (0 / 0)
 
White Papers: 0 (0 / 0)
 
Registered on BiotechScienceNews: 0

3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.